China’s NDRC Approves Health Care Steps On Hospitals, Foreign Doctors Among Others
This article was originally published in PharmAsia News
China’s National Development and Reform Commission decentralized or canceled five health care-related administrative approvals among 50 measures across a wide variety of policy areas, including sole proprietorship hospital establishments by Hong Kong, Macau and Taiwan investors.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.